Table 5 Comparison of drug treatment among the four clusters
| Â | Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | p-value |
|---|---|---|---|---|---|
Young healthy | Middle aged | Middle aged obese | Elderly | ||
Antibiotics, n (%) | 17 (6.5) | 49 (20.3) | 83 (19.2) | 90 (24.1) | < 0.0001 |
Azithromycin, n (%) | 21 (7.9) | 29 (12) | 50 (11.6) | 63 (16.9) | 0.0066 |
Ciclesonide, n (%) | 35 (13.3) | 48 (19.9) | 77 (17.9) | 52 (14) | 0.0957 |
Favipiravir, n (%) | 29 (10.9) | 92 (38) | 168 (38.8) | 130 (34.8) | < 0.0001 |
Hydroxychloroquine, n (%) | 0 (0) | 2 (0.8) | 2 (0.5) | 2 (0.5) | 0.5759 |
Lopinavir and Ritonavir, n (%) | 1 (0.4) | 2 (0.8) | 0 (0) | 2 (0.5) | 0.3684 |
Remdesivir, n (%) | 10 (3.8) | 53 (22) | 85 (19.8) | 68 (18.5) | < 0.0001 |
Nafamostat, n (%) | 3 (1.1) | 15 (6.2) | 39 (9.1) | 26 (7.1) | < 0.0001 |
Anticoagulant, n (%) | 15 (5.6) | 48 (19.8) | 86 (19.9) | 98 (26.1) | < 0.0001 |
Glucocorticoids, n (%) | 25 (9.4) | 100 (40.8) | 219 (50.6) | 179 (48) | < 0.0001 |